Scholarlink

<p>A series of ten chloro- and bromo-substituted isatin derivatives were synthesized and evaluated for their ability to inhibit the monoamine oxidase (MAO) enzymes. All compounds demonstrated more potent inhibition of MAO-A compared to MAO-B. The most potent MAO-A inhibitor was <b>HIB2</b> (IC<sub>50</sub> = 0.037&#xa0;μM), followed by <b>HIB4</b> (IC<sub>50</sub> = 0.039&#xa0;μM), while <b>HIB10</b> (IC<sub>50</sub> = 0.125&#xa0;μM) exhibited the most potent inhibition of MAO-B. <b>HIB2</b> was identified as a specific MAO inhibitor with a selectivity index of 29 for MAO-A over MAO-B. The enzyme-inhibitor dissociation constants (K<sub>i</sub>) for <b>HIB2</b> and <b>HIB10</b> were 0.031&#xa0;μM and 0.036&#xa0;μM, respectively, for MAO-A and MAO-B. Both <b>HIB2</b> and <b>HIB10</b> exhibited competitive and reversible inhibition. An analysis of the ADMET and PAMPA suggested that <b>HIB2</b> is permeable to the blood–brain barrier (BBB). Molecular docking analysis revealed that <b>HIB2</b> forms stable hydrogen bonds with Asn181 and Gln215 in the MAO-A ligand–protein complex. Dynamic analysis indicated the stability of <b>HIB2</b> with MAO-A. These findings suggest that <b>HIB2</b> is potent reversible MAO-A inhibitor, making this class of compounds potential therapeutic agents for neurological disorders.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Assembling of phenyl substituted halogens in the C3-position of substituted isatins by mono wave assisted synthesis: development of a new class of monoamine oxidase inhibitors

  • 期刊论文

  • 发表日期：

    2025年9月19日

查看全文
  • Della Grace Thomas Parambi,
  • Stephanus J. Cloete,
  • Sunil Kumar,
  • Tariq Ghazi Alsahli,
  • Arafa Musa,
  • Sumera Qasim,
  • Muzammil Kabier,
  • Sachithra Thazhathuveedu Sudevan,
  • Saranya Kattil Parmbil,
  • Anél Petzer,
  • Jacobus P. Petzer,
  • Bijo Mathew

摘要

A series of ten chloro- and bromo-substituted isatin derivatives were synthesized and evaluated for their ability to inhibit the monoamine oxidase (MAO) enzymes. All compounds demonstrated more potent inhibition of MAO-A compared to MAO-B. The most potent MAO-A inhibitor was HIB2 (IC50 = 0.037 μM), followed by HIB4 (IC50 = 0.039 μM), while HIB10 (IC50 = 0.125 μM) exhibited the most potent inhibition of MAO-B. HIB2 was identified as a specific MAO inhibitor with a selectivity index of 29 for MAO-A over MAO-B. The enzyme-inhibitor dissociation constants (Ki) for HIB2 and HIB10 were 0.031 μM and 0.036 μM, respectively, for MAO-A and MAO-B. Both HIB2 and HIB10 exhibited competitive and reversible inhibition. An analysis of the ADMET and PAMPA suggested that HIB2 is permeable to the blood–brain barrier (BBB). Molecular docking analysis revealed that HIB2 forms stable hydrogen bonds with Asn181 and Gln215 in the MAO-A ligand–protein complex. Dynamic analysis indicated the stability of HIB2 with MAO-A. These findings suggest that HIB2 is potent reversible MAO-A inhibitor, making this class of compounds potential therapeutic agents for neurological disorders.